Soc. Generale Call 1.9 AT1 20.09..../ DE000SW2GE64 /
21/06/2024 21:38:26 | Diferencia-0.180 | Bid8:01:48 | Ask- | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
2.270EUR | -7.35% | 2.260 Volumen de oferta: 1,400 |
- Tamaño/ Volumen/ Formato de Ask: - |
AROUNDTOWN EO-,01 | 1.90 EUR | 20/09/2024 | Call |
GlobeNewswire
8:00
First gene therapy for prevalent pathologies in neurology receives FDA IND clearance - EG 427 initi...
GlobeNewswire
7:30
PolTREG’s type-1 diabetes Treg cell therapy PTG-007 demonstrates long-term safety and efficacy for u...
GlobeNewswire
7:30
OSE Immunotherapeutics Announces Commercial and Revenue Sharing Agreement in the Field of CAR T-cell...
GlobeNewswire
7:00
Valneva Announces Health Canada Approval of the World’s First Chikungunya Vaccine, IXCHIQ®
GlobeNewswire
6:20
China's Hangzhou empowers urban development with world-class power supply reliability
GlobeNewswire
3:00
SALESFORCE ALERT: Bragar Eagel & Squire, P.C. is Investigating Salesforce, Inc. on Behalf of Salesfo...
GlobeNewswire
3:00
NIKE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página